General Information
Drug ID
DR00552
Drug Name
Imipramine
Synonyms
1-(3-Dimethylaminopropyl)-4,5-dihydro-2,3,6,7-dibenzazepine; 10,11-Dihydro-5-(3-(dimethylamino)propyl)-5H-dibenz[b,f]azepine; 10,11-Dihydro-N,N-dimethyl-5H-dibenz[b,f]azepine-5-propanamine; 2,2'-(3-Dimethylaminopropylimino)bibenzyl; 2,2'-(3-Dimethylaminopropylimino)dibenzyl; 3-(10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethylpropan-1-amine; 3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N,N-dimethylpropan-1-amine; 5,6-Dihydro-N-(3-(dimethylamino)propyl)-11H-dibenz(b,e)azepine; 5,6-Dihydro-N-[3-(dimethylamino)propyl]-11H-dibenz[b,e]azepine; 5-(3-(Dimethylamino)propyl)-10,11-dihydro-5H-dibenz(b,f)azepine; 5-(3-Dimethylaminopropyl)-10,11-dihydro-5H-dibenzo(b,f)azepine; 5H-Dibenz(b,f)azepine,5-[3-(dimethylamino)propyl]-10,11-dihydro-mixed with ethyl alcohol; 5H-Dibenz(b,f)azepine-5-propanamine, 10,11-dihydro-N,N-dimethyl-(9CI); Antideprin; Antideprin (TN); Berkomine; Censtim; Censtin; Declomipramine; Deprimin (TN); Deprinol (TN); Depsonil (TN); Dimipressin; Dpid; Dyna-zina; Dynaprin; Dynaprin (TN); Eupramin; Eupramin (TN); G-22355; Imavate; Imidobenzyle; Imipramil (TN); Imipramin; Imipramina; Imipramina [INN-Spanish]; Imipramina [Italian]; Imipramine (INN); Imipramine [INN:BAN]; Imipraminum; Imipraminum [INN-Latin]; Imiprin; Imizin; Imizinum; Impramine; Intalpram; Iramil; Irmin; Irmin (TN); Janimine; Janimine (TN); Janimine (hydrochloride); Melipramin; Melipramin (TN); Melipramine; N-(3-Dimethylaminopropyl)-o-iminodibenzyl; N-(gamma-Dimethylaminopropyl)iminodibenzyl; N-(gamma.-Dimethylaminopropyl)iminodibenzyl; Nelipramin; Norchlorimipramine; Norfranil; Pramine; Prazepine; Promiben;Psychoforin; SK-Pramine; Surplix; Surplix (TN); Timolet; Tofranil; Tofranil (free base); Tofranil (hydrochloride); Tofranil(TN); Tofranil, base; Tofraniln A
Drug Type
Small molecular drug
Indication Major depressive disorder [ICD11: 6A70.3] Approved [1]
Therapeutic Class
Antidepressants
Structure
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=3696"></iframe>
3D MOL 2D MOL
Formula
C19H24N2
Canonical SMILES
CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31
InChI
InChI=1S/C19H24N2/c1-20(2)14-7-15-21-18-10-5-3-8-16(18)12-13-17-9-4-6-11-19(17)21/h3-6,8-11H,7,12-15H2,1-2H3
InChIKey
BCGWQEUPMDMJNV-UHFFFAOYSA-N
CAS Number
CAS 50-49-7
Pharmaceutical Properties Molecular Weight 280.415 Topological Polar Surface Area 6.5
Heavy Atom Count 21 Rotatable Bond Count 4
Hydrogen Bond Donor Count 0 Hydrogen Bond Acceptor Count 2
XLogP
4.8
PubChem CID
3696
PubChem SID
10524418 , 11111330 , 11111331 , 11335734 , 11360973 , 11363809 , 11366371 , 11368933 , 11371492 , 11373530 , 11377095 , 11461945 , 11466100 , 11467220 , 11484795 , 11485940 , 11488806 , 11490282 , 11491831 , 11494729 , 15222228 , 26751600 , 29214791 , 29222819 , 3249403 , 442469 , 46507351 , 47365159 , 47588968 , 47736449 , 47736450 , 47736451 , 47810727 , 47885381 , 48110430 , 48110431 , 49698865 , 49761601 , 49961519 , 50100256 , 50104254 , 53788900 , 57288535 , 57321945 , 615226 , 7548657 , 7849629 , 7979599 , 8152336 , 9261
ChEBI ID
ChEBI:47499
TTD Drug ID
D06ZUK
DT(s) Transporting This Drug P-GP Transporter Info P-glycoprotein 1 Substrate [2]
References
1 Imipramine was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019)
2 Caco-2 permeability, P-glycoprotein transport ratios and brain penetration of heterocyclic drugs. Int J Pharm. 2003 Sep 16;263(1-2):113-22.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.